Table 1 Patient characteristics.
From: Changes in corneal higher-order aberrations during treatment for infectious keratitis
Characteristics | |
Number of eyes, n | 98 |
Age (years) | 50 (34–65) |
Sex (female/male), n | 46/52 |
Patients background factor, n | |
Use of contact lens | 47 |
Diabetes mellitus | 6 |
Post-trauma | 4 |
Atopy | 3 |
Aetiology of infectious keratitis, n | |
Bacteria | 62 |
Fungi | 14 |
Acanthamoeba | 14 |
Herpes simplex virus | 8 |
Duration from onset to treatment initiation (days) | 3 (1–14) |
Duration to epithelialization (days) | 20 (9–36) |
Duration to healing (days) | 50 (28–90) |
Number of medications | 3 (2–4) |
Pretreatment corneal findings | |
Area of infiltration (mm2), | 10.2 (4.7–25.3) |
Location of the corneal lesion, n | |
Central/paracentral/peripheral | 55/85/34 |
Neovascularization before treatment (+ / −) | 12/86 |
Corneal opacity grade before treatment, n Grade 1/Grade 2/Grade 3 | 8/23/67 |
Posttreatment corneal findings | |
Scar area after healing (mm2) | 3.0 (0.8–12.0) |
Neovascularization after treatment (+ / −) | 16/82 |
Corneal opacity grade after treatment, n Grade 0/Grade 1/Grade 2/Grade 3 | 16/42/27/13 |
Corneal thickening after treatment, n | 4 |
Corneal thinning after treatment, n | 24 |
BSCVA before treatment (logMAR units) | 1.11 (0.30–1.76) |
BSCVA after treatment (logMAR units) | 0.10 (− 0.07–0.52) |
